Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)

Market Cap	5.19B
Revenue (ttm)	462.72M
Net Income (ttm)	120.87M
Shares Out	127.08M
EPS (ttm)	0.95
PE Ratio	42.87
Forward PE	n/a
Dividend	1.20 (2.95%)
Ex-Dividend Date	Jul 18, 2025

Volume	604,171
Average Volume	718,715
Open	41.10
Previous Close	40.86
Day's Range	40.70 - 41.10
52-Week Range	33.10 - 45.00
Beta	0.82
RSI	60.91
Earnings Date	Apr 30, 2026

About Assure Tech (Hangzhou)

Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China. It is also involved in POCT and plastic product manufacturing; online sales; pharmaceutical sales; and medical testing. In addition, the company offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veterinary tests, as well as Biochemistry, chronic disease monitoring systems, and reader and analyzers. Further, it offers infectious disease, fertility, fe...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 741
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688075

Financial Performance

In 2024, Assure Tech (Hangzhou)'s revenue was 540.70 million, an increase of 7.42% compared to the previous year's 503.36 million. Earnings were 192.30 million, an increase of 35.85%.